Management have mismanaged the good news. Lot's of institutions and mum and dad investors are down a packet. Another massive loss today. Down 25% from today's high. This share surely must rebound after a 54% retrace. VWAP must be close to 70 cents since the FDA approval. We should see a dead cat bounce tomorrow, hopefully to 65 cents. Only time will tell. The patient will be rewarded.
LBT Price at posting:
51.0¢ Sentiment: Buy Disclosure: Held
